Search research articles
Contact Us
Filters
Showing results (131-140 of 175) with videos related to
Page
of 18
Sort By:
British Journal of Haematology
|
November 22, 2020
COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial
Marquita Camilleri, Jonathan Sive, William Wilson, et al.
Frontiers in Oncology
|
August 9, 2021
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma
Catherine S Y Lecat, Jessica B Taube, William Wilson, et al.
American Journal of Medical Genetics. Part A
|
June 7, 2007
Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome
Karen W Gripp, Angela E Lin, Linda Nicholson, et al.
Frontiers in Immunology
|
March 15, 2021
Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma
Lydia Lee, Nouf Alrasheed, Garima Khandelwal, et al.
British Journal of Haematology
|
March 26, 2026
Results from the prospective phase 2 multicentre UK PBSC haplo trial using PTCy pre- or post-stem cells
Hugues deLavallade, William Wilson, Rachel Protheroe, et al.
British Journal of Haematology
|
August 20, 2024
PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia
Jaimal Kothari, Toby Eyre, Ali Rismani, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study
Samantha C Burnham, Nandini Raghavan, William Wilson, et al.
Therapeutic Advances in Medical Oncology
|
November 12, 2020
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study
Valerie E Crolley, Daire Hanna, Nalinie Joharatnam-Hogan, et al.
American Journal of Industrial Medicine
|
January 31, 2019
Occupational medicine clinical practice data reveal increased injury rates among Hispanic workers
Scott M Riester, Karyn L Leniek, Ashley D Niece, et al.
Cancer Medicine
|
February 4, 2026
A Digital Health Approach to Improve Compliance With Surveillance Colonoscopy Guidelines: The SCOPES Program: Study protocol for a stepped-wedge cluster trial
Erin L Symonds, Geraldine Laven-Law, Isabelle Keel, et al.
Page
of 18
Search research articles
Search
Showing results (131-140 of 175) with videos related to
Sort By:
Page
of 18
British Journal of Haematology
|
November 22, 2020
COVID-19 and myeloma clinical research - experience from the CARDAMON clinical trial
Marquita Camilleri, Jonathan Sive, William Wilson, et al.
Frontiers in Oncology
|
August 9, 2021
Defining Unmet Need Following Lenalidomide Refractoriness: Real-World Evidence of Outcomes in Patients With Multiple Myeloma
Catherine S Y Lecat, Jessica B Taube, William Wilson, et al.
American Journal of Medical Genetics. Part A
|
June 7, 2007
Further delineation of the phenotype resulting from BRAF or MEK1 germline mutations helps differentiate cardio-facio-cutaneous syndrome from Costello syndrome
Karen W Gripp, Angela E Lin, Linda Nicholson, et al.
Frontiers in Immunology
|
March 15, 2021
Increased Immune-Regulatory Receptor Expression on Effector T Cells as Early Indicators of Relapse Following Autologous Stem Cell Transplantation for Multiple Myeloma
Lydia Lee, Nouf Alrasheed, Garima Khandelwal, et al.
British Journal of Haematology
|
March 26, 2026
Results from the prospective phase 2 multicentre UK PBSC haplo trial using PTCy pre- or post-stem cells
Hugues deLavallade, William Wilson, Rachel Protheroe, et al.
British Journal of Haematology
|
August 20, 2024
PembroWM: A phase II trial to investigate the safety and efficacy of rituximab and pembrolizumab in relapsed/refractory Waldenström's Macroglobulinaemia
Jaimal Kothari, Toby Eyre, Ali Rismani, et al.
Journal of Alzheimer'S Disease : JAD
|
September 25, 2015
Novel Statistically-Derived Composite Measures for Assessing the Efficacy of Disease-Modifying Therapies in Prodromal Alzheimer's Disease Trials: An AIBL Study
Samantha C Burnham, Nandini Raghavan, William Wilson, et al.
Therapeutic Advances in Medical Oncology
|
November 12, 2020
COVID-19 in cancer patients on systemic anti-cancer therapies: outcomes from the CAPITOL (COVID-19 Cancer PatIenT Outcomes in North London) cohort study
Valerie E Crolley, Daire Hanna, Nalinie Joharatnam-Hogan, et al.
American Journal of Industrial Medicine
|
January 31, 2019
Occupational medicine clinical practice data reveal increased injury rates among Hispanic workers
Scott M Riester, Karyn L Leniek, Ashley D Niece, et al.
Cancer Medicine
|
February 4, 2026
A Digital Health Approach to Improve Compliance With Surveillance Colonoscopy Guidelines: The SCOPES Program: Study protocol for a stepped-wedge cluster trial
Erin L Symonds, Geraldine Laven-Law, Isabelle Keel, et al.
Page
of 18